FDA panel recommends easing restrictions on several peptides, including BPC-157
A Food and Drug Administration advisory committee narrowly voted in favor of loosening restrictions on peptides over strong objections from agency career scientists. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Throughout the daylong meeting, FDA scientists detailed a lack of evidence supporting the use of the peptides … Read more